METFORMIN HYDROCHLORIDE
- Product NDC
- 71335-0886
- 11-digit product format
- 713350886
- Labeler code
- 71335
- Product ID
- 71335-0886_f6130cb6-f4ba-47c1-bfe1-a9089ef4d524
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- metformin hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA201991
- Marketing category
- ANDA
- Marketing start
- 2013-03-01
- Substance
- METFORMIN HYDROCHLORIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Biguanide [EPC], Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- METFORMIN HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METFORMIN HYDROCHLORIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 786Z46389E |
| Rxcui | 860975 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-0886-1 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-2 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-3 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-4 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-5 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-6 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-7 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-8 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-9 | 2025-08-25 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-7 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-8 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
| 71335-0886-9 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1222-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1995 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-0886-1 | METFORMIN HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 5 |
| 71335-0886-2 | METFORMIN HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 5 |
| 71335-0886-3 | METFORMIN HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 5 |
| 71335-0886-4 | METFORMIN HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 5 |
| 71335-0886-5 | METFORMIN HYDROCHLORIDE | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | | 5 |
| 71335-0886-6 | METFORMIN HYDROCHLORIDE | 15 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 15 | | 5 |
| 71335-0886-7 | METFORMIN HYDROCHLORIDE | 45 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 45 | | 5 |
| 71335-0886-8 | METFORMIN HYDROCHLORIDE | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | | 5 |
| 71335-0886-9 | METFORMIN HYDROCHLORIDE | 20 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 20 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-0886 | METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | Current NDC, Legacy NDC, 9 package rows | 20220202_f2318509-9a49-4c99-a08b-22381f17aacd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0886-1 | 71335088601 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-1) | 2018-08-20 | 0000-00-00 | No | No | Current |
| 71335-0886-2 | 71335088602 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-2) | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0886-3 | 71335088603 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-3) | 2018-07-17 | 0000-00-00 | No | No | Current |
| 71335-0886-4 | 71335088604 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-4) | 2018-08-07 | 0000-00-00 | No | No | Current |
| 71335-0886-5 | 71335088605 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-5) | 2018-06-28 | 0000-00-00 | No | No | Current |
| 71335-0886-6 | 71335088606 | 15 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-6) | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0886-7 | 71335088607 | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-7) | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0886-8 | 71335088608 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-8) | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0886-9 | 71335088609 | 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0886-9) | 2021-12-27 | 0000-00-00 | No | No | Current |